Polycystic liver diseases.
Polycystic liver diseases (PCLDs) are genetic disorders with heterogeneous etiologies and a range of phenotypic presentations. PCLD exhibits both autosomal or recessive dominant pattern of inheritance and is characterized by the progressive development of multiple cysts, isolated or associated with polycystic kidney disease, that appear more extensive in women. Cholangiocytes have primary cilia, functionally important organelles (act as mechanosensors) that are involved in both normal developmental and pathological processes. The absence of polycystin-1, 2, and fibrocystin/polyductin, normally localized to primary cilia, represent a potential mechanism leading to cyst formation, associated with increased cell proliferation and apoptosis, enhanced fluid secretion, abnormal cell-matrix interactions, and alterations in cell polarity. Proliferative and secretive activities of cystic epithelium can be regulated by estrogens either directly or by synergizing growth factors including nerve growth factor, IGF1, FSH and VEGF. The abnormalities of primary cilia and the sensitivity to proliferative effects of estrogens and different growth factors in PCLD cystic epithelium provide the morpho-functional basis for future treatment targets, based on the possible modulation of the formation and progression of hepatic cysts.
Experimental Medicine, University of L'Aquila, L'Aquila, Italy.
P
P
Onori
A
A
Franchitto
R
R
Mancinelli
G
G
Carpino
D
D
Alvaro
H
H
Francis
G
G
Alpini
E
E
Gaudio
D001652:Bile Ducts / Q000473:pathology; D003560:Cysts / Q000235:genetics; D004847:Epithelial Cells / Q000473:pathology; D005260:Female; D006801:Humans; D008107:Liver Diseases / Q000235:genetics; D008297:Male; D050396:TRPP Cation Channels / Q000502:physiology
D050396:TRPP Cation Channels